Sumitomo Mitsui Trust Holdings, Inc. Vaxcyte, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $145 Billion
- Q4 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 5,363 shares of PCVX stock, worth $400,401. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,363
Previous 5,649
5.06%
Holding current value
$400,401
Previous $644,000
31.83%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PCVX
# of Institutions
350Shares Held
130MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$893 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$790 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$742 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$649 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$464 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.43B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...